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Whole exome sequencing was conducted on a father and two sons with severe 
ADHD, combined hyperactive and inattentive subtype, all of whom improved with 
treatment with stimulant medication in an adult ADHD clinical trial. Exome capture 
was done using a commercially available Agilent SureSelect in solution method. 
Paired end sequencing was performed using the Illumina Genome Analyzer IIx 
platform with read lengths of 76 base pairs, providing at least 20x-coverage. 
Sequence reads were aligned to human reference genome builds hg18 and hg19 
using both Novoalign 2.07 and SOAPaligner 2.20. Single nucleotide polymorphism 
(SNP) calling was conducted using both Maq 0.5.0 and SOAPsnp 1.03. SNP results 
were filtered as followed: Base quality > 20, depth from 4-200, copy number estimate 
< 2, and distance between two adjacent SNPs no less than 5. Nonsynonymous SNPs 
(nsSNPs) were identified using ANNOVAR and USeq Alleler, and insertions/deletions 
(indels) were detected using SOAPindel. Illumina 610k SNP microarrays were also 
run on each of the three samples, with copy number variant (CNV) detection using 
PennCNV.
ADHD is a common disorder affecting more than 1 in 20 children in the U.S., with as 
many as 50% remaining symptomatic into adulthood. Genetic factors are thought to 
play a large role in the etiology of the disorder, but studies thus far have been 
inconsistent, accounting for a small portion of the risk for ADHD. It is hypothesized 
that rare, family-specific genetic variants may account for the remaining missing 
heritability of ADHD, and advances in next-generation sequencing have made whole 
exome sequencing a potentially viable option for gene variant finding in complex 
disease pedigrees. Exome sequencing has identified the causes of nearly a dozen 
Mendelian disorders. Whether exome sequencing can be used to find risk variants for 
complex traits and has clinical utility as a diagnostic tool remain to be explored. Here 
we examined the utility of exome sequencing to identify candidate genes for attention 
deficit/hyperactivity disorder (ADHD) in a Utah pedigree in which ADHD clustered in 
an apparently Mendelian pattern.
Whole Exome Sequencing Reveals the Genetic Basis of a Case of Idiopathic 
Hemolytic Anemia and Suggests Candidate Rare Variants for ADHD in a Utah Pedigree
Preliminary results show four interesting candidate rare
nonsynonymous variants in brain-expressed genes that are shared
among 3 individuals (father and two sons) and thus may be
associated with ADHD in this family. Validation of these findings is
underway in each individual, along with expansion of the pedigree to
include DNA sequence and phenotype data from the unaffected
mother and other siblings, along with functional characterization of
the nsSNPs and PKLR mutations. These preliminary results show
that exome sequencing can identify genetic causes of mendelian
disorders, as in the case of pyruvate kinase deficiency in one
member of this family, and also has potential to discover rare
variants associated with complex neuropsychiatric conditions such
as ADHD.
Collectively, our results identify new candidate genes for ADHD, and 
suggest that exome sequencing may be an efficient strategy for 
solving diagnostic unknowns.
Analysis and filtering of shared novel variants among three family members with ADHD identified 29 candidate variants. 
Comparison to variant data from ~6,300 exomes revealed that 12 of these variants have minor allele frequency >0.2%.  In 
addition, one family member, who had undergone a splenectomy for idiopathic hemolytic anemia, was found to have two rare 
non-synonymous mutations in PKLR, consistent with a diagnosis of red blood cell pyruvate kinase deficiency.  This finding 
was confirmed by functional biochemical testing the majority of the SNPs were validated by Sanger sequencing, and 
validation of the indels is underway.
Table 3. 29 candidate variants for ADHD and their population frequencies in other cohorts
ExomeCapture 84060 84615 92157
Number of genomic positions for calling SNPs 52,105,343 52,105,343 52,105,343
Number of high-confidence genotypes* 46,651,026 45,555,039 46,393,954
Number of high-confidence genotypes in target regions 35,571,754 34,856,090 35,742,301
Number of known SNPs in target region 192,415 192,415 192,415






Total number of novel SNPs 25,523 24,470 25,321
Total number of novel indels 335 325 335
# chrom Position in HG18 Reference allele
Mutant 


















chr17 64384287 A G ABCA8 Nonsynonymous C1387R 0 0.00% 0 0.00%
chr11 68323378 G A CPT1A Nonsynonymous L193F 0 0.00% 0 0.00%
chr8 101063450 A G RGS22 Nonsynonymous I1084T 0 0.00% 0 0.00%
chr18 59805227 G T SERPINB8 Nonsynonymous G287V 0 0.00% 0 0.00%
chr1 205267500 - T C1orf116 frameshift insertion 34 1.40% 0 0.00%
chr17 42571111 - TGGC CDC27 frameshift insertion 5 0.20% 0 0.00%
chr17 42589406 A - CDC27 frameshift deletion 31 1.30% 0 0.00%
chr1 109266693 TTC - GPSM2 amino acid deletion 9 0.40% 0 0.00%
chr9 8577604 AT - HNRNPK frameshift deletion 37 1.60% 0 0.00%
chr11 5432010 - CA OR51I2 frameshift insertion 15 0.60% 0 0.00%
chr17 36038691 C - SMARCE1 frameshift deletion 19 0.80% 0 0.00%
chr7 98839005 C - PDAP1 frameshift deletion 37 1.60% 1 0.20%
chr18 27355154 T G DSG2 Nonsynonymous V158G 1 ~0.0% 1 0.20%
chr3 127359980 G A ALDH1L1 Nonsynonymous P107L 2 ~0.0% 0 0.00%
chr13 51440681 A G ATP7B Nonsynonymous V536A 1 ~0.0% 1 0.20%
chr10 53128652 A C CSTF2T Nonsynonymous C222G 4 0.10% 1 0.20%
chr14 21041859 G A METTL3 Nonsynonymous R36W 9 0.20% 1 0.20%
chr11 76632438 - A GDPD4 frameshift insertion 36 1.50% 6 1.00%
chr7 86998554 A T ABCB1 Nonsynonymous S893T 815 14.3%1 9 1.50%
chr11 133634133 C G ACAD8 Nonsynonymous S171C 112 2.00% 20 3.30%
chr20 17904347 C T C20orf72 Nonsynonymous R178W 23 0.40% 8 1.30%
chr8 33438433 T C FUT10 Nonsynonymous Q27R 15 0.30% 3 0.50%
chr13 19695025 A T GJB6 Nonsynonymous S199T 68 1.20% 4 0.70%
chr16 69572830 G T HYDIN Nonsynonymous P1491H 77 1.40% dozens >5.0%
chr10 22059861 G A MLLT10 Nonsynonymous R713H 15 0.30% 6 1.00%
chr17 10355994 A G MYH1 Nonsynonymous Y435H 99 1.70% 14 2.30%
chr1 143727234 G T PDE4DIP Nonsynonymous L142I 1256 22.10% hundreds >30.0%
chr2 98175864 T C VWA3B Nonsynonymous I513T 15 0.30% 16 2.70%






PK (U/gHb) 3.3  L 8.6 6.1 – 12.3
HK (U/gHb) 3.2  H 1.1 0.8 – 1.5
G6PD (U/gHb) 15.8  H 9.2 6.4 – 10.5
Table 2. Biochemical assays of enzyme activities in the patient 
affected with idiopathic hemolytic anemia confirmed PKLR deficiency. 






Figure 1. Identification of family-specific ADHD candidate genes by ANNOVAR stepwise reduction 
procedure, based on shared variants among 3 patients and assuming a dominant disease model. 
Figure 2: Pedigree of a Utah family affected with idiopathic hemolytic 
anemia and ADHD. 
